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Prosthetic medical device-associated infections are responsible for significant morbidity and mortality rates. Novel
improved materials and surfaces exhibiting inappropriate conditions for microbial development are urgently
required in the medical environment. This study reveals the benefit of using natural Mentha piperita essential oil,
combined with a 5 nm core/shell nanosystem-improved surface exhibiting anti-adherence and antibiofilm
properties. This strategy reveals a dual role of the nano-oil system; on one hand, inhibiting bacterial adherence and,
on the other hand, exhibiting bactericidal effect, the core/shell nanosystem is acting as a controlled releasing
machine for the essential oil. Our results demonstrate that this dual nanobiosystem is very efficient also for inhibiting
biofilm formation, being a good candidate for the design of novel material surfaces used for prosthetic devices.Background
Staphylococcus aureus was recognized as a major patho-
gen soon after its discovery in the late nineteenth cen-
tury. This organism causes a broad range of conditions,
ranging from asymptomatic colonization to severe inva-
sive infections which can progress to complicated sep-
ticemia, osteomyelitis, septic arthritis, or endocarditis
[1,2]. S. aureus is a major cause of nosocomial infections
and is responsible for significant morbidity, mortality,
and an extended hospital stay [3,4]. This Gram-positive
bacterium possesses specific surface proteins such as
fibronectin-binding proteins, collagen-binding proteins,
and fibrinogen-binding proteins, which have been impli-
cated as mediators in specific bacterial binding to the
extracellular matrix and subsequent biofilm development
[1,5-7].
The increased use of prosthetic devices during the past
decades has been accompanied by a constantly increased
number of prosthetic device infections [8]. S. aureus is a
widespread bacterium, being found on the skin and mu-
cosa of healthy persons; therefore, prosthesis-associated
infections incriminating this pathogen are frequently* Correspondence: grumezescu@yahoo.com
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reproduction in any medium, provided the origencountered [9]. Prosthesis-associated infections could be
the results of microbial colonization by three routes:
(a) direct inoculation at the time of implantation, (b)
hematogenous spreading during bacteremia, or (c) direct
contiguous spreading from an adjacent infectious focus
[10].
One of the most severe complications is a biofilm-
associated infection of a prosthetic device due to the fact
that biofilm bacteria are different from planktonic cells,
being usually more resistant. The biofilm cells are resistant
to all kinds of antimicrobial substances: antibiotics, anti-
septics, disinfectants; this kind of resistance, consecutive
to biofilm formation, is phenotypic, behavioral, and more
recently, called tolerance [43,44].
Among the promising approaches to combat biofilm
infections is the generation of surface modification of
devices to reduce microbial attachment and biofilm devel-
opment as well as incorporation of antimicrobial agents to
prevent colonization. Essential oils (EOs) and their com-
ponents are gaining increasing interest in the food, cos-
metic, and pharmaceutical industries because of their
relatively safe status, their wide acceptance by consumers,
and their exploitation for potential multi-purpose func-
tional use [11].
Plants of the genus Mentha produce a class of natural
products known as mono-terpenes (C10), characterizedger. This is an Open Access article distributed under the terms of the Creative
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only sources for the production of one of the most eco-
nomically important essential oil, menthol, throughout
the world [12]. Mentha piperita, commonly called pepper-
mint, is a well-known herbal remedy used for a variety of
symptoms and diseases, recognized for its carminative,
stimulating, antispasmodic, antiseptic, antibacterial, and
antifungal activities [4,13,14]. However, their use for
clinical purposes is limited by the high volatility of the
major compounds.
Due to their high biocompatibility [15] and superpara-
magnetic behavior, magnetite nanoparticles (Fe3O4) have
attracted attention to their potential applications espe-
cially in biomedical fields [16,17], such as magnetic reson-
ance imaging [18-20], hyperthermia [21], biomedical
separation and purification [22], bone cancer treatment
[21], inhibition of biofilm development [23,24], stabi-
lization of volatile organic compounds [25], antitumoral
treatment without application of any alternating magnetic
field [26], drug delivery or targeting [27-33], modular
microfluidic system for magnetic-responsive controlled
drug release, and cell culture [34].This paper reports a
new nano-modified prosthetic device surface with anti-
pathogenic properties based on magnetite nanoparticles
and M. piperita essential oil.
Methods
Materials
All chemicals were used as received. FeCl3 (99.99%),
FeSO4·7H2O (99.00%), NH3(28% NH3 in H2O, ≥99.99%
trace metal basis), lauric acid (C12) (98.00%), CHCl3
(anhydrous, ≥99%, contains 0.5% to 1.0% ethanol as
stabilizer),and CH3OH (anhydrous, 99.8%) were purchased
from Sigma-Aldrich. Prosthetic device represented by cath-
eter sections were obtained from ENT (Otolarincology),
Department of Coltea Hospital, Bucharest, Romania.
Fabrication of nano-modified prosthetic device
For the fabrication of the nano-modified prosthetic device,
we used a recently published method [35] in order to de-
sign a new anti-pathogenic surface coated with nanofluid
by combining the unique properties of magnetite nano-
particles to prevent biofilm development and the anti-
microbial activity of M. piperita essential oil.
M. piperita plant material was purchased from a local
supplier and subjected to essential oil extraction. A Neo
Clevenger-type apparatus was used to perform microwave-
assisted extractions. Chemical composition was settled by
GC-MS analysis according to our recently published paper
[36].
Magnetite (Fe3O4) is usually prepared by precipitation
method [37-39]. The core/shell nanostructure used in
this paper was prepared and characterized using a
method we previously described [40]. Briefly, sodiumlaurate (C12) was added under stirring to a basic aqueous
solution of NH3, and then FeSO4/FeCl3 (1:2 molar ratio)
was dropped under continuous stirring up to pH = 8,
leading to the formation of a black precipitate. The
product was repeatedly washed with methanol and sepa-
rated with a strong NdFeB permanent magnet. The
obtained powder was identified as magnetite by XRD.
Dimension of the core/shell structure not exceeding 5 nm
and their spherical shape were confirmed by TEM ana-
lysis. The FT-IR analysis identified the organic coating
agent, i.e., lauric acid on the surface of the magnetite
nanoparticles. In order to fabricate a modified surface of
prosthetic device, core/shell/EO nanofluid was used to
create a coated shell. The layer of core/shell/EO nanofluid
on the prosthetic device was achieved by submerging the
catheter pieces in 5 mL of nanofluid (represented by solu-
bilized core/shell/EO in CHCl3 (0.33% w/v) aligned in a
magnetic field of 100 kgf applied for 1 s.
The catheter pieces were allowed to dry at room
temperature. The rapid drying was facilitated by the
convenient volatility of chloroform [41]. The coated
prosthetic devices were then sterilized by ultraviolet ir-
radiation for 15 min. Figure 1 presents a schematic rep-
resentation of biofilm development on the surface of the
prosthetic device coated/uncoated with anti-pathogenic
nanofluid.
TG analysis
The thermogravimetric (TG) analysis of theFe3O4@C12
and Fe3O4@C12@EO was followed with a Netzsch TG
449C STA Jupiter instrument (Netzsch, Selb, Germany).
Samples were screened with 200 mesh prior to analysis,
placed in an alumina crucible, and heated at 10 K·min−1
from room temperature to 800°C, under the flow of 20
mL min−1of dried synthetic air (80% N2 and 20% O2).
Biofilm development on nano-modified prosthetic device
surface
The adherence of S. aureus ATCC 25923 was investigated
in six multiwell plates using a static model for monospe-
cific biofilm developing. Catheter pieces of 1 cm with and
without coated shell were distributed in plastic wells (one
per well) and immersed in the liquid culture medium
represented by nutrient broth. The plastic wells were
inoculated with 300 μL of 0.5 McFarland microbial sus-
pensions and incubated for 24 h at 37°C. After incubation
the culture medium was removed, and the prosthetic
device samples were washed three times in phosphate buf-
fered saline (PBS) in order to remove the nonadherent
strains and moved into sterile wells. Then, fresh broth was
added, the incubation being continued for 72 h. Viable cell
counts (VCCs) have been achieved for both working
variants (coated and uncoated prosthetic devices) after 24,
48, and 72 h of incubation, respectively, in order to
Figure 1 Biofilm development on the surface of the prosthetic device coated/uncoated with anti-pathogenic nanofluid. (a)
staphylococcal biofilm development on the surface of the prosthetic device, (b) nano-modified surface of the prosthetic device, (c) inhibition of
staphylococcal biofilm development on the nano-modified surface of the prosthetic device.
Figure 2 TGA diagram of Fe3O4@C12 and Fe3O4@C12@EO.
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the inhibitory effect exhibited by the proposed coating sys-
tem. The adhered cells have been removed from the cath-
eter sections by vortexing and brief sonication, and serial
tenfold dilutions ranging from 10−4 to 10−12 of the
obtained inocula have been spotted on Muller-Hinton
agar, incubated for 24 h at 37°C, and assessed for VCCs
[23,42]. All tests were performed in triplicate.
Characterization of biofilm development on the surface of
nano-modified prosthetic device
After 24, 48, and 72 h of incubation, the samples prepared
as described above were removed from the plastic wells,
washed three times with PBS, fixed with cold methanol,
and dried before microscopic examination. The biofilm
development on the surface of coated and uncoated pros-
thetic devices was visualized using a Hitachi S2600N scan-
ning electron microscope (SEM; Tokyo, Japan) at 25 keV,
in primary electron fascicles, on samples covered with a
thin silver layer.
Results and discussion
The increasing occurrence of multiresistant pathogenic
bacterial strains has gradually rendered traditional anti-
microbial treatment ineffective. The prognosis is worsened
by the formation of bacterial biofilms on the biomaterials
used in medicine, even if the planktonic cells are suscep-
tible to some antibiotics. Public reports stated that 60% to
85% of all microbial infections involve biofilms developed
on natural intact or damaged tissues or artificial devices
[43]. These infections are characterized by slow onset,
middle-intensity symptoms, chronic evolution, and high
tolerance to antibiotics and other antimicrobials [44].
The efficiency of essential oils, polyphenolic extracts
obtained from foregoing plants, and their synergic effects
as alternative strategies for the treatment of severe infec-
tions caused by highly resistant bacteria was tested on
the following species: methicillin-resistant S. aureus,
extended-spectrum beta-lactamases producing Escherichia
coli, and multiresistant Pseudomonas aeruginosa [8]. Pre-
vious studies have demonstrated that the mint essential
oil (Mentha sp.) exhibited synergistic inhibitory effects
with low pH and sodium chloride against Listeria and
inhibited some organisms such as S. aureus, E. coli,Candida albicans, Acinetobacter baumanii, Entero-
coccus faecalis, Klebsiella pneumoniae, Salmonella enter-
ica subsp. enterica serotype Typhimurium, and Serratia
marcescens [45]. The analyzed M. piperita EO proved to
be rich in β-pinene, limonene, menthone, isomenthol,
and menthol. These results are in concordance with
reported literature [46,47]. We have suggested before the
efficiency of nanosystem-vectored essential oil strategy
[23]. The Fe3O4/C12 nanoparticles seem not to be cyto-
toxic on the HEp2 cell line, which is a great advantage
for the in vivo use of these nanostructure systems for bio-
medical applications with minor risks of the occurrence
of side effects [48].
TG analysis is plotted in Figure 2. The mass loss of
EO is up to approximately 170°C, while the mass loss of
C12 is between 170°C and 375°C. To avoid errors due to
overlapping the two regions of weight loss, EO content
was estimated as the difference between weight loss for
the region at approximately 375°C for both materials,
and it is approximately 17.3%.
The dynamics of viable cells embedded in the biofilm
developed on the catheter device samples showed a signifi-
cant decrease of the biofilm viable cells, as compared with
the uncoated surface (Figure 3). The number of biofilm-
embedded cells at 24, 48, and 72 h was almost the same in
the case of the coated surface. By comparison, in the case
of the uncoated device surface, an ascendant trend of the
VVCs was observed for the three analyzed time points.
These results suggest that the antibiofilm effect of the
Figure 3 Viable cell counts recovered from S. aureus biofilms
developed on the (nano-modified) catheter pieces. Samples
were plated after 24h, 48h and 72h of incubation.
Figure 4 SEM micrographs of in vitro staphylococcal biofilm developm
prosthetic device sections, (2) nano-coated prosthetic device sections, (a) s
prosthetic device.
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release of the essential oil compounds from the coating.
SEM images support the quantitative data, revealing the
presence of a well-developed biofilm on the uncoated cath-
eter, as compared with the functionalized one (Figure 4).
Taken together, these results are demonstrating that the
proposed solution for obtaining a nano-modified pros-
thetic device is providing an additional barrier to S. aureus
colonization, an aspect which is very important for the re-
adjustment of the treatment and prevention of infections
associated with prosthetic devices.
Conclusions
In this study, we report the fabrication of a 5 nm core/
shell nanostructure combined with M. piperita essential
oil to obtain a unique surface coating with improved re-
sistance to bacterial adherence and further developmentent on the surface of prosthetic devices. (1) Unmodified
urface of the prosthetic device, and (b) transversal section of the
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http://www.nanoscalereslett.com/content/8/1/6of staphylococcal biofilm. The obtained results proved
that the proposed strategy is manifesting a dual benefit
due to its anti-adherence and microbicidal properties. The
microbicidal effect could be explained by the stabilization,
decrease of volatility, and controlled release of the essen-
tial oil from the core/shell nanostructure. The results
reveal a great applicability for the biomedical field, open-
ing new directions for the design of anti-pathogenic film-
coated-surface-based core/shell nanostructure and natural
products.
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